M De Martino Selected Research

M De Martino Research Topics

Disease

3	HIV Infections (HIV Infection) 01/2019 - 07/2000
3	Tuberculosis (Tuberculoses) 06/2013 - 04/2012
2	Stomach Neoplasms (Stomach Cancer) 12/2023 - 12/2016
2	Anaphylaxis (Anaphylactic Shock) 01/2014 - 04/2006
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2012 - 11/2009
2	Latex Hypersensitivity (Latex Allergy) 04/2008 - 04/2007
2	Infections 07/2007 - 10/2005
2	Diarrhea 07/2007 - 07/2006
1	Wounds and Injuries (Trauma) 07/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Septic Shock (Toxic Shock Syndrome) 02/2020
1	Hypersensitivity (Allergy) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 04/2013
1	Communicable Diseases (Infectious Diseases) 04/2013
1	Macrophage Activation Syndrome 04/2013
1	Malaria 04/2013
1	Opportunistic Infections (Opportunistic Infection) 08/2010
1	Inappropriate ADH Syndrome (SIADH) 02/2010
1	Pharyngitis (Sore Throat) 01/2010
1	Necrosis 09/2009
1	Cystic Fibrosis (Mucoviscidosis) 02/2009
1	Heart Arrest (Cardiac Arrest) 01/2009
1	Flushing 01/2009
1	Neutropenia 12/2008
1	IgA Deficiency 12/2008
1	Allergic Rhinitis 04/2008
1	Body Weight (Weight, Body) 07/2007
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 07/2007
1	Inflammation (Inflammations) 07/2007
1	Disease Progression 07/2007
1	Papillomavirus Infections 06/2007
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2007
1	Fever (Fevers) 10/2006
1	Eosinophilia 10/2006
1	Urticaria (Hives) 10/2006
1	Angioedema 10/2006
1	Weight Gain 10/2006
1	Deafness (Deaf Mutism) 05/2006
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 05/2006

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2023 - 06/2007
3	Interferon-gamma (Interferon, gamma)IBA 06/2013 - 04/2012
3	InterferonsIBA 07/2012 - 01/2012
2	Trastuzumab (Herceptin)FDA Link 12/2023 - 12/2016
2	Lapatinib (GW572016)FDA Link 12/2023 - 12/2016
2	Etanercept (Enbrel)FDA Link 09/2009 - 05/2006
2	LatexIBA 04/2008 - 04/2007
2	CytokinesIBA 07/2007 - 07/2000
1	GlycoconjugatesIBA 01/2023
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2014
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2014
1	MacrolidesIBA 01/2014
1	SteroidsIBA 04/2013
1	Complement System Proteins (Complement)IBA 01/2012
1	Complement Factor H (Factor H)IBA 01/2012
1	EpitopesIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2012
1	Vasopressins (Vasopressin)IBA 02/2010
1	SodiumIBA 02/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	AntigensIBA 01/2010
1	Macrophage Migration-Inhibitory FactorsIBA 11/2009
1	Tobramycin (Nebcin)FDA LinkGeneric 02/2009
1	PotassiumIBA 01/2009
1	Immunoglobulins (Immunoglobulin)IBA 12/2008
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2008
1	AllergensIBA 04/2008
1	Tryptases (Tryptase)IBA 04/2008
1	Nasal SpraysIBA 04/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2007
1	Ophthalmic Solutions (Eye Drops)IBA 07/2007
1	Xylose (D-Xylose)FDA Link 07/2007
1	2- cyano- 3- hydroxy- N- (4- (trifluoromethyl)phenyl)- 2- hepten- 6- ynamideIBA 07/2007
1	Hormones (Hormone)IBA 07/2007
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2007
1	Combined VaccinesIBA 06/2007
1	Neutralizing AntibodiesIBA 06/2007
1	Interleukin-5 (Interleukin 5)IBA 10/2006
1	Interleukin-4 (Interleukin 4)IBA 10/2006
1	Immunoglobulin E (IgE)IBA 10/2006
1	Immunoglobulin M (IgM)IBA 10/2006
1	PyrimidinesIBA 07/2006
1	Ketorolac Tromethamine (Acular)FDA LinkGeneric 04/2006
1	Lopinavir FDA Link 10/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2005

Therapy/Procedure

1	Oral Surgery (Maxillofacial Surgery) 07/2023
1	Orthognathic Surgery 07/2023
1	Operative Surgical Procedures 07/2023
1	Extracorporeal Membrane Oxygenation 02/2020
1	Artificial Respiration (Mechanical Ventilation) 02/2020
1	Prenatal Care (Care, Prenatal) 01/2019
1	Therapeutics 04/2013
1	Art Therapy 08/2010
1	Transition to Adult Care 08/2010
1	Warm Ischemia 01/2009
1	Laparotomy 01/2009
1	Heart Massage 01/2009
1	Premedication 04/2008
1	Highly Active Antiretroviral Therapy (HAART) 10/2005